Karnatak Ruchi, Agarwal Anjoo, Asnani Mona, Singh Renu
Obstetrics and Gynaecology, King George's Medical University (KGMU), Lucknow, IND.
Cureus. 2022 Jul 29;14(7):e27433. doi: 10.7759/cureus.27433. eCollection 2022 Jul.
Objective To study the status of insulin resistance (IR) in non-polycystic ovary syndrome (PCOS) infertile women and to assess its effects on response to ovulation induction (OI) with clomiphene citrate (CC). Methods and materials A prospective cohort study was conducted at the Department of Obstetrics and Gynecology, King George Medical University, Lucknow, India, over a one-year period. One hundred two women who underwent treatment for infertility were enrolled and evaluated for insulin resistance. Insulin resistance was assessed using fasting serum insulin levels and the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) index. All participants were given ovulation induction with clomiphene citrate and were then followed up for the occurrence of ovulation and conception. Results Insulin resistance was found in 20.5% of infertile subjects and 95.4% of anovulatory subjects. Of the subjects with insulin resistance, 80.5% showed monofollicular development. The pregnancy rate was 5.8%, but there was no conception among subjects with insulin resistance. Conclusions Insulin resistance was found to be present in 20.5% of infertile women. Women with insulin resistance are more likely to have monofollicular development on ovulation induction and are less likely to conceive as compared with women without insulin resistance (OR = 0.2079).
目的 研究非多囊卵巢综合征(PCOS)不孕女性的胰岛素抵抗(IR)状况,并评估其对枸橼酸氯米芬(CC)促排卵(OI)反应的影响。方法与材料 在印度勒克瑙乔治国王医科大学妇产科进行了一项为期一年的前瞻性队列研究。纳入102例接受不孕症治疗的女性,并对其胰岛素抵抗进行评估。采用空腹血清胰岛素水平和胰岛素抵抗稳态模型评估(HOMA-IR)指数评估胰岛素抵抗。所有参与者均接受枸橼酸氯米芬促排卵治疗,随后随访排卵和受孕情况。结果 在不孕受试者中,20.5%存在胰岛素抵抗,在无排卵受试者中,95.4%存在胰岛素抵抗。在有胰岛素抵抗的受试者中,80.5%表现为单卵泡发育。妊娠率为5.8%,但有胰岛素抵抗的受试者未受孕。结论 发现20.5%的不孕女性存在胰岛素抵抗。与无胰岛素抵抗的女性相比,有胰岛素抵抗的女性在促排卵时更易出现单卵泡发育,受孕可能性更低(OR = 0.2079)。